Caterpillar Inc vs Stryker Corporation — how do they compare? Caterpillar Inc trades at $713.37 (market cap $327.89B), while Stryker Corporation trades at $305.2 (market cap $115.62B). The key difference: Caterpillar Inc is far larger — about 2.8× Stryker Corporation's market cap, and Stryker Corporation pays the higher dividend (1.17%). Which is the better fit depends on your goals — on Pluang, investors hold Caterpillar Inc for 96 Days and Stryker Corporation for 21 Days on average.
| CAT | SYK | |
|---|---|---|
Market Cap | $327.89B | $115.62B |
Volume | 2,472,211 | 2,265,074 |
Sector | Industrials | Health |
52-Week High | $1.06K | $387.46 |
52-Week Low | $524.47 | $269.75 |
Typical Hold Time | 96 Days | 21 Days |
Enterprise Value | $366.32B | $127.08B |
Dividend Yield | 0.91% | 1.17% |
Signals from Pluang's Aura AI — not financial advice
Caterpillar (CAT) trades at $692.13, up 0.75% on the day, with a bearish technical signal but strong fundamental performance. The company has beaten EPS estimates for three consecutive quarters, with Q3 2026 results pending. Revenue reached $67.59 billion in 2025, and net income margin stands at 14.51%. Analysts maintain a bullish consensus with a $933.67 price target, while recent news highlights expansion in quarry automation.
The stock offers growth potential from operational efficiency and automation initiatives, but faces risks from economic cyclicality and high valuation multiples. Institutional activity is mixed, with some trimming positions. The current price is below the consensus target, suggesting upside if earnings momentum continues, though technical indicators signal near-term caution.
Stryker (SYK) trades at $304.00, down 0.76% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company reported strong profitability with a net income margin of 14.43% and ROE of 16.51% for 2026. Recent earnings show a beat in Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. Positive cash flow trends and a consensus analyst price target of $365.89 suggest upside potential, though news of legal investigations and a manufacturing issue have introduced volatility.
The outlook for SYK is supported by solid fundamentals and analyst optimism, with 71% of covering analysts rating it a Buy. Key opportunities include margin expansion and product innovation, but risks from ongoing legal scrutiny and operational challenges could pressure the stock. Investors should weigh the strong financial health against near-term headline risks ahead of the Q3 earnings report.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Caterpillar Inc. designs, manufactures, and markets construction, mining, and forestry machinery. The Company also manufactures engines and other related parts for its equipment, and offers financing and insurance. Caterpillar distributes its products through a worldwide organization of dealers.
Read more on CAT →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →